Development and characterisation of ibuprofen-loaded nanoemulsion with enhanced oral bioavailability

Lipophilic compounds constitute a majority of therapeutics in the pipeline of drug discovery. Despite possessing enhanced efficacy and permeability, some of these drugs suffer poor solubility necessitating the need of a suitable drug delivery system. Nanoemulsion is a drug delivery system that provi...

Full description

Bibliographic Details
Published in:Heliyon
Main Author: Anuar N.; Sabri A.H.; Bustami Effendi T.J.; Abdul Hamid K.
Format: Article
Language:English
Published: Elsevier Ltd 2020
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088803374&doi=10.1016%2fj.heliyon.2020.e04570&partnerID=40&md5=d621fcb917d8ee3bac32a9b49e807998
id 2-s2.0-85088803374
spelling 2-s2.0-85088803374
Anuar N.; Sabri A.H.; Bustami Effendi T.J.; Abdul Hamid K.
Development and characterisation of ibuprofen-loaded nanoemulsion with enhanced oral bioavailability
2020
Heliyon
6
7
10.1016/j.heliyon.2020.e04570
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088803374&doi=10.1016%2fj.heliyon.2020.e04570&partnerID=40&md5=d621fcb917d8ee3bac32a9b49e807998
Lipophilic compounds constitute a majority of therapeutics in the pipeline of drug discovery. Despite possessing enhanced efficacy and permeability, some of these drugs suffer poor solubility necessitating the need of a suitable drug delivery system. Nanoemulsion is a drug delivery system that provides enhanced solubility for poorly soluble drugs in an attempt to improve the oral bioavailability. The purpose of this study is to develop a nanoemulsion system using ibuprofen as a model drug in order to investigate the potential of this colloidal system to enhance the absorption of poorly water-soluble drugs. Ibuprofen loaded-nanoemulsion with different drug concentrations (1.5, 3 and 6% w/w) were formulated from olive oil, sucrose ester L-1695 and glycerol using D-phase emulsification technique. A pseudoternary phase diagram was utilised to identify the optimal excipient composition to formulate the nanoemulsion system. In vitro diffusion chamber studies using rodent intestinal linings highlighted improved absorption profile when ibuprofen was delivered as nanoemulsion in comparison to microemulsions and drug-in-oil systems. This was further corroborated by in vivo studies using rat model that highlighted a two-fold increase in ibuprofen absorption when the drug was administered as a nanoemulsion relative to drug-in-oil system. On the other hand, when ibuprofen was administered as microemulsions, only a 1.5-fold increase in absorption was observed relative to drug-in-oil system. Thus, this study highlights the potential of using nanoemulsion as a drug delivery system to enhance the oral bioavailability of hydrophobic drugs. © 2020 The Author(s); Ibuprofen; Nanoemulsion; Intestinal transport; Pharmacokinetic profile; Oral delivery; Bioavailability, Transepithelial electrical resistance (TEER); Nanomaterials; Materials characterization; Pharmaceutical science; Dose-response relationship; Nanotechnology. © 2020 The Author(s)
Elsevier Ltd
24058440
English
Article
All Open Access; Gold Open Access
author Anuar N.; Sabri A.H.; Bustami Effendi T.J.; Abdul Hamid K.
spellingShingle Anuar N.; Sabri A.H.; Bustami Effendi T.J.; Abdul Hamid K.
Development and characterisation of ibuprofen-loaded nanoemulsion with enhanced oral bioavailability
author_facet Anuar N.; Sabri A.H.; Bustami Effendi T.J.; Abdul Hamid K.
author_sort Anuar N.; Sabri A.H.; Bustami Effendi T.J.; Abdul Hamid K.
title Development and characterisation of ibuprofen-loaded nanoemulsion with enhanced oral bioavailability
title_short Development and characterisation of ibuprofen-loaded nanoemulsion with enhanced oral bioavailability
title_full Development and characterisation of ibuprofen-loaded nanoemulsion with enhanced oral bioavailability
title_fullStr Development and characterisation of ibuprofen-loaded nanoemulsion with enhanced oral bioavailability
title_full_unstemmed Development and characterisation of ibuprofen-loaded nanoemulsion with enhanced oral bioavailability
title_sort Development and characterisation of ibuprofen-loaded nanoemulsion with enhanced oral bioavailability
publishDate 2020
container_title Heliyon
container_volume 6
container_issue 7
doi_str_mv 10.1016/j.heliyon.2020.e04570
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088803374&doi=10.1016%2fj.heliyon.2020.e04570&partnerID=40&md5=d621fcb917d8ee3bac32a9b49e807998
description Lipophilic compounds constitute a majority of therapeutics in the pipeline of drug discovery. Despite possessing enhanced efficacy and permeability, some of these drugs suffer poor solubility necessitating the need of a suitable drug delivery system. Nanoemulsion is a drug delivery system that provides enhanced solubility for poorly soluble drugs in an attempt to improve the oral bioavailability. The purpose of this study is to develop a nanoemulsion system using ibuprofen as a model drug in order to investigate the potential of this colloidal system to enhance the absorption of poorly water-soluble drugs. Ibuprofen loaded-nanoemulsion with different drug concentrations (1.5, 3 and 6% w/w) were formulated from olive oil, sucrose ester L-1695 and glycerol using D-phase emulsification technique. A pseudoternary phase diagram was utilised to identify the optimal excipient composition to formulate the nanoemulsion system. In vitro diffusion chamber studies using rodent intestinal linings highlighted improved absorption profile when ibuprofen was delivered as nanoemulsion in comparison to microemulsions and drug-in-oil systems. This was further corroborated by in vivo studies using rat model that highlighted a two-fold increase in ibuprofen absorption when the drug was administered as a nanoemulsion relative to drug-in-oil system. On the other hand, when ibuprofen was administered as microemulsions, only a 1.5-fold increase in absorption was observed relative to drug-in-oil system. Thus, this study highlights the potential of using nanoemulsion as a drug delivery system to enhance the oral bioavailability of hydrophobic drugs. © 2020 The Author(s); Ibuprofen; Nanoemulsion; Intestinal transport; Pharmacokinetic profile; Oral delivery; Bioavailability, Transepithelial electrical resistance (TEER); Nanomaterials; Materials characterization; Pharmaceutical science; Dose-response relationship; Nanotechnology. © 2020 The Author(s)
publisher Elsevier Ltd
issn 24058440
language English
format Article
accesstype All Open Access; Gold Open Access
record_format scopus
collection Scopus
_version_ 1814778506704322560